mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |